137 related articles for article (PubMed ID: 7973684)
1. Risk from low-dose exposures.
Monro AM
Science; 1994 Nov; 266(5188):1141. PubMed ID: 7973684
[No Abstract] [Full Text] [Related]
2. Risk from low-dose exposures.
Zendzian RP
Science; 1994 Nov; 266(5188):1142-3. PubMed ID: 7973686
[No Abstract] [Full Text] [Related]
3. Risk from low-dose exposures.
Portier CJ; Lucier GW; Edler L
Science; 1994 Nov; 266(5188):1141-2. PubMed ID: 7973685
[No Abstract] [Full Text] [Related]
4. Risk from low-dose exposures.
Strauss BS
Science; 1994 Nov; 266(5188):1143-4. PubMed ID: 7973688
[No Abstract] [Full Text] [Related]
5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
6. Risk assessments of low-level exposures.
Abelson PH
Science; 1994 Sep; 265(5178):1507. PubMed ID: 7832844
[No Abstract] [Full Text] [Related]
7. Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments.
Gottmann E; Kramer S; Pfahringer B; Helma C
Environ Health Perspect; 2001 May; 109(5):509-14. PubMed ID: 11401763
[TBL] [Abstract][Full Text] [Related]
8. Risk assessments of low-level exposures.
Smith SJ; Chen AT; Caudill SP; Wetterhall SF; Sever LE
Science; 1995 Feb; 267(5198):603-4. PubMed ID: 7839131
[No Abstract] [Full Text] [Related]
9. Extrapolation of carcinogenicity between species: qualitative and quantitative factors.
Gold LS; Manley NB; Ames BN
Risk Anal; 1992 Dec; 12(4):579-88. PubMed ID: 1480802
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk assessment: historical perspectives, current issues, and future directions.
Velazquez SF; Schoeny R; Rice GE; Cogliano VJ
Drug Chem Toxicol; 1996 Aug; 19(3):161-85. PubMed ID: 8933022
[No Abstract] [Full Text] [Related]
11. Detection and measurement of protein adducts: aspects of risk assessment.
Ehrenberg L
Prog Clin Biol Res; 1991; 372():79-87. PubMed ID: 1956950
[No Abstract] [Full Text] [Related]
12. On the use of historical control data for trend test in carcinogenicity studies.
Sun J
Biometrics; 1999 Dec; 55(4):1273-6. PubMed ID: 11315082
[TBL] [Abstract][Full Text] [Related]
13. Prediction of carcinogenic potential of chemicals using repeated-dose (13-week) toxicity data.
Woutersen RA; Soffers AE; Kroese ED; Krul CA; van der Laan JW; van Benthem J; Luijten M
Regul Toxicol Pharmacol; 2016 Nov; 81():242-249. PubMed ID: 27614137
[TBL] [Abstract][Full Text] [Related]
14. Re: pulmonary tumor types induced in Wistar rats of the so-called "19-dust study".
Morfeld P; Borm P
Exp Toxicol Pathol; 2007 Aug; 58(6):407; author reply 409. PubMed ID: 17560773
[No Abstract] [Full Text] [Related]
15. Carcinogenicity testing of eliglustat in mice and rats.
Dagher R; Watzinger M; Chevalier G; Thirion-Delalande C; Gervais F; Forster R
Regul Toxicol Pharmacol; 2015 Oct; 73(1):401-12. PubMed ID: 26232705
[TBL] [Abstract][Full Text] [Related]
16. A measure of tumorigenic potency incorporating dose-response shape.
Meier KL; Bailer AJ; Portier CJ
Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
[TBL] [Abstract][Full Text] [Related]
17. Statistical evaluation of mortality in long-term carcinogenicity bioassays using a Williams-type procedure.
Herberich E; Hothorn LA
Regul Toxicol Pharmacol; 2012 Oct; 64(1):26-34. PubMed ID: 22749913
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk assessment of direct acting carcinogens.
Zito R
J Exp Clin Cancer Res; 1999 Sep; 18(3):273-8. PubMed ID: 10606168
[No Abstract] [Full Text] [Related]
19. A molecular approach to cancer risk.
Stone R
Science; 1995 Apr; 268(5209):356-7. PubMed ID: 7716533
[No Abstract] [Full Text] [Related]
20. Chemical carcinogenesis: too many rodent carcinogens.
Ames BN; Gold LS
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7772-6. PubMed ID: 2217209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
